New diagnosis tool; Zytiga affordable
A new risk assessment tool for GPs is set to revolutionise PCa diagnosis. See here. And NICE has agreed that abiraterone (Zytiga) is affordable after a lower price was agreed with the makers. See here.
Author Archives: wpadm1n
More accurate predictions ?
Patients might be offered a more accurate prediction of their PCa risk with a novel method developed by Cambridge University researchers. See here
Biopsies may be ‘out’
Urologists are committed to rolling out diagnostic use of the new MRI scans once their benefits are officially confirmed. The scans make it possible to rule out the need for a biopsy in many men who don’t have a clinically significant PCa. See here. Latest on this here.
Buddies home support update
This Macmillan service offered support for adult cancer patients in our areas and they have been working on re-starting face-to-face visits again. The Bristol Buddies service has moved to its national telephone service. Ring 07543 248714 or see this site for support.
Treatments and questions – Left Column
Active surveillance – pro-active monitoring of early stage cancer with the intent to cure. Watchful waiting – regular check-ups possibly leading to hormone treatment or palliative care. This is offered to men who are likely to die from other causes. Surgery – an operation to remove the prostate, suitable for localised cancer. There are three […]
Recommended UK websites, but beware
Those unfamiliar with obtaining information from the World Wide Web should be on guard that the information available can be highly variable in quality. Dealing with a life-threatening disease means you have to be aware that some sites may be highly misleading and even promote treatments that can be ineffective or even dangerous. For useful […]
About prostate cancer
Know your risk
Prostate Cancer UK has a new infographic and booklets. Exchange information www.myprostate.eu is now also available in English and prostate cancer patients can exchange information and help each other with treatment decisions.
Incidence with age
Incidence with age In 2008 in the UK 37,000 men were diagnosed with prostate cancer. About 100 a day. Of the men diagnosed: A few hundred were under 50 years old ~3,709 were 50-59 ~12,201 were 60-69 ~13,682 were 70-79 ~7,109 were 80 or over
Help with treatment choices
Get enhanced guidance on treatment options, thanks to a checklist developed by researchers (Jun ’17). See. More help here. And why it’s difficult to choose among treatment options (Jul ’17). See. Men with early stage prostate cancer wishing to preserve sexual function while on treatment do not always make the right choices. See